Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

St. Jude Medical Inc and CardioMEMS announces FDA approval of CardioMEMS heart failure management system


Wednesday, 28 May 2014 12:38pm EDT 

St. Jude Medical Inc and CardioMEMS:U.S. Food and Drug Administration (FDA) approval of CardioMEMS HF System.CardioMEMS HF System is first and only FDA-approved heart failure (HF) monitoring device that has been proven to significantly reduce HF hospital admissions when used by physicians to manage heart failure.CardioMEMS HF System uses a miniaturized, wireless monitoring sensor that is implanted in the pulmonary artery. 

Company Quote

67.17
-0.06 -0.09%
19 Dec 2014